PubMed=3746026
Ueda M., Maeda T., Yamada T., Miyawaki Y., Otsuki Y., Okamoto Y., Okamura S., Sano T., Ueki M., Sugimoto O.
Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervix.
Nihon Sanka Fujinka Gakkai Zasshi 38:1071-1078(1986)

PubMed=2486664
Ueda M., Ueki M., Yamada T., Okamoto Y., Maeda T., Sugimoto O., Otsuki Y.
Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1).
Hum. Cell 2:401-410(1989)

PubMed=2531191
Ueda M., Misaki O., Yamada T., Okamoto Y., Goto M., Maeda T., Okamura S., Ueki M., Sugimoto O.
In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines -- comparison between squamous cell carcinoma and adenocarcinoma.
Nihon Sanka Fujinka Gakkai Zasshi 41:1423-1430(1989)

DOI=10.1267/ahc.26.515
Tsuchida K., Okamoto Y., Yamada T., Ueda M., Iijima J., Shiina Y., Hirano H., Rokukawa C., Kasama T., Taki T., Handa S., Ueki M., Adachi K.
Discrimination of metastatic cells from mesothelial cells in effusion cytology by monoclonal antibody AD117m directed against lactotetraosylceramide.
Acta Histochem. Cytochem. 26:515-530(1993)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)